About This Deal

Blackstone acquired Clarus (Blackstone Life Sciences), a transaction completed in November 2018.

Clarus (Blackstone Life Sciences) operates in Life sciences investing, is based in Boston and San Francisco, USA.

Acquiring Clarus established Blackstone Life Sciences, a new platform able to invest across the life-cycle of companies and products, pairing Clarus's scientific and clinical-development expertise with Blackstone's scale to fund growth-stage investments and R&D collaborations with biopharmaceutical companies.

Deal Terms

Acquirer
Blackstone
Target
Clarus (Blackstone Life Sciences)
Value
Not disclosed
Date
November 2018
Type
Acquisition
Status
Ready

Transaction Details

Target HQ
Boston and San Francisco, USA
Segment
Life sciences investing
Closed
November 30, 2018

Advisors

Advisory firms were not disclosed for this transaction.

Related Deals & Entities

Sources: Press release ↗ · SEC filing ↗

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.